Recombinase efficiency increases allow Qi Biodesign to insert 20-30 kb (5 or 6 genes) at one time at one location across a variety of different crop genetics. In addition, a large team at Qi Biodesign ...
Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.
Educational institutions and research organisations in and around Tiruchi celebrated the National Science Day with a host of ...
18h
Hosted on MSNJP Morgan Downgrades Intellia Therapeutics (NTLA)Fintel reports that on February 28, 2025, JP Morgan downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from ...
Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.
Recent breakthroughs and regulatory shifts in gene editing might be the key to moving from treating the symptoms of diseases ...
Neuroblastoma is a solid tumor that occurs in children. When high-risk, the disease has a poor prognosis. Decades ago, adding the drug retinoic acid ...
Proposed cuts to the National Institutes of Health's funding to universities could threaten critical research, including ...
Nvidia's Jetson family facilitates edge computing. Edge computing processes data near its source instead of in a centralized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results